Yang Xuan1, Xīn Gào1, Bernd Holleczek2, Hermann Brenner3, Ben Schöttker4. 1. Division of Clinical Epidemiology and Ageing Research, German Cancer Research Center, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany; Network Aging Research, University of Heidelberg, Bergheimer Straße 20, 69120 Heidelberg, Germany. 2. Saarland Cancer Registry, Präsident Baltz-Straße 5, 66119 Saarbrücken, Germany. 3. Division of Clinical Epidemiology and Ageing Research, German Cancer Research Center, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany; Network Aging Research, University of Heidelberg, Bergheimer Straße 20, 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. 4. Division of Clinical Epidemiology and Ageing Research, German Cancer Research Center, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany; Network Aging Research, University of Heidelberg, Bergheimer Straße 20, 69120 Heidelberg, Germany. Electronic address: b.schoettker@dkfz.de.
Abstract
BACKGROUND: Oxidative stress contributes to endothelial dysfunction and is involved in the pathogenesis of cardiovascular diseases (CVD). However, large population-based cohort studies are sparse and biomarkers of oxidative stress have not been evaluated for CVD risk prediction so far. METHODS: The associations of urinary oxidized guanine/guanosine (OxGua) levels (including 8-hydroxy-2'-deoxyguanosine (8-OHdGuo)) and 8-isoprostane levels with myocardial infarction, stroke and CVD mortality were examined in a population-based cohort of 9949 older adults from Germany with 14 years of follow-up in multivariable adjusted Cox proportional hazards models. RESULTS: Both OxGua and 8-isoprostane levels were associated with CVD mortality independently from other risk factors (hazard ratio (HR) [95% confidence interval] of top vs. bottom tertile: 1.32 [1.06; 1.64] and 1.58 [1.27; 1.98], respectively). Moreover, CVD mortality risk prediction was significantly improved when adding the two biomarkers to the European Society of Cardiology's Systematic Coronary Risk Evaluation (ESC SCORE) tool. The area under the curve (AUC) increased from 0.739 to 0.752 (p = 0.001). In addition, OxGua levels were associated with stroke incidence (HR for 1 standard deviation increase: 1.07 [1.01; 1.13]) and 8-isoprostane levels were associated with fatal stroke incidence (HR of top vs. bottom tertile: 1.77 [1.09; 2.89]). With respect to myocardial infarction, associations were observed for both biomarkers in obese subjects (BMI ≥ 30 kg/m2). CONCLUSIONS: These results from a large cohort study add evidence to the involvement of an imbalanced redox system to the etiology of CVD. In addition, 8-isoprostane and OxGua measurements were shown to be useful for an improved CVD mortality prediction.
BACKGROUND: Oxidative stress contributes to endothelial dysfunction and is involved in the pathogenesis of cardiovascular diseases (CVD). However, large population-based cohort studies are sparse and biomarkers of oxidative stress have not been evaluated for CVD risk prediction so far. METHODS: The associations of urinary oxidized guanine/guanosine (OxGua) levels (including 8-hydroxy-2'-deoxyguanosine (8-OHdGuo)) and 8-isoprostane levels with myocardial infarction, stroke and CVD mortality were examined in a population-based cohort of 9949 older adults from Germany with 14 years of follow-up in multivariable adjusted Cox proportional hazards models. RESULTS: Both OxGua and 8-isoprostane levels were associated with CVD mortality independently from other risk factors (hazard ratio (HR) [95% confidence interval] of top vs. bottom tertile: 1.32 [1.06; 1.64] and 1.58 [1.27; 1.98], respectively). Moreover, CVD mortality risk prediction was significantly improved when adding the two biomarkers to the European Society of Cardiology's Systematic Coronary Risk Evaluation (ESC SCORE) tool. The area under the curve (AUC) increased from 0.739 to 0.752 (p = 0.001). In addition, OxGua levels were associated with stroke incidence (HR for 1 standard deviation increase: 1.07 [1.01; 1.13]) and 8-isoprostane levels were associated with fatal stroke incidence (HR of top vs. bottom tertile: 1.77 [1.09; 2.89]). With respect to myocardial infarction, associations were observed for both biomarkers in obese subjects (BMI ≥ 30 kg/m2). CONCLUSIONS: These results from a large cohort study add evidence to the involvement of an imbalanced redox system to the etiology of CVD. In addition, 8-isoprostane and OxGua measurements were shown to be useful for an improved CVD mortality prediction.
Authors: Mary Rezk-Hanna; Umme Shefa Warda; Andrew C Stokes; Jessica Fetterman; Jian Li; Paul M Macey; Muhammad Darawad; Yeonsu Song; Ziyad Ben Taleb; Mary-Lynn Brecht; Neal L Benowitz Journal: Nicotine Tob Res Date: 2022-06-15 Impact factor: 5.825
Authors: Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Hongji Chen; Andrew A Maudsley; Sulaiman Sheriff; Shuo Chen; Anya Savransky; Wyatt Marshall; Meghann C Ryan; Heather A Bruce; Alan R Shuldiner; Braxton D Mitchell; Peter Kochunov; L Elliot Hong Journal: Proc Natl Acad Sci U S A Date: 2019-11-21 Impact factor: 11.205
Authors: Ankita Anusruti; Yang Xuan; Xīn Gào; Eugène H J M Jansen; Dana Clarissa Laetsch; Hermann Brenner; Ben Schöttker Journal: BMJ Open Diabetes Res Care Date: 2020-02